Pee test vs. scope: which do bladder cancer patients prefer?
NCT ID NCT06126796
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study asked 107 people with a history of non-muscle invasive bladder cancer whether they preferred a non-invasive urine test (CxBladder Monitor) or the standard cystoscopy (a thin tube inserted into the bladder) for routine cancer surveillance. Participants tried both methods and reported their preference and satisfaction. The goal is to see if the easier urine test could be a more comfortable option for regular check-ups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CxBladder Monitor (urine-based molecular test)
What this could lead to
If successful, this could show that patients prefer a simple urine test over an invasive scope for routine bladder cancer check-ups, potentially making surveillance less uncomfortable.
What could go wrong
This is a small, completed study focused on patient preference, not on whether the urine test catches cancer as well as cystoscopy. The test might miss some recurrences, so it may not replace cystoscopy entirely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON MUSCLE INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States